Insulet Corp (PODD)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$131.85

Buy

$138.76

arrow-up$3.93 (+2.98%)

Prices updated at 06 Oct 2026, 00:42 EDT

Prices minimum 15 mins delay

Prices in USD

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated throu ...

NASDAQ

1.05%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	2,072m	2,708m
	1,446m	1,940m
	309m	474m
	14.91	17.50
	418m	247m
	424m	489m
Sales, General and administrative	917m	1,165m
Interest expenses	43m	59m
Provision for income taxes	-118m	92m
Operating expenses	1,137m	1,466m
Income before taxes	300m	340m
Net income available to common shareholders	418m	247m
	5.97	3.51
Net interest income	-3m	-25m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	5.78	3.48
Free cash flow per share	2.8552	5.6038
Book value/share	15.9268	19.6659
Debt equity ratio	1.069742	0.614268

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	1,891m	1,914m
Current liabilities	528m	680m
Total capital	2,508m	2,446m
Total debt	1,392m	949m
Total equity	1,212m	1,515m
Total non current liabilities	-	-
Loans	1,296m	931m
Total assets	3,088m	3,190m
Total liabilities	-	-
Cash and cash equivalents	953m	716m
Common stock	70m	70m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	704m	953m
Cash dividends paid	-	-
	296m	350m
Investments (gains) losses	-146m	-223m
	953m	716m
Net income	-	-
	430m	569m
	-134m	-219m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.